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To cause an infection, bacteriophages must penetrate the alginate exopolysaccharide of Pseudomonas aerugi-
nosa to reach the bacterial surface. Despite a lack of intrinsic motility, phage were shown to diffuse through
alginate gels at alginate concentrations up to 8% (wt/vol) and to bring about a 2-log reduction in the cell
numbers in 20-day-old biofilms of P. aeruginosa. The inability of alginate to act as a more effective diffusional
barrier suggests that phage may cause a reduction in the viscosity of the exopolysaccharide. Samples (n 5 5)
of commercial alginate and purified cystic fibrosis (CF) alginate were incubated with 2 3 108 purified phage
per ml for 24 h at 37°C. After incubation the samples and controls were subjected to rheological analysis with
a Carrimed controlled stress rheometer. The viscosities of phage-treated samples were reduced by up to 40%
compared to those of controls incubated in the absence of phage. The experiment was repeated by using phage
concentrations of 1010 and 1012 phage per ml and samples taken for analysis at intervals up to 4 h. The results
indicated that there was a time- and concentration-dependent reduction in viscosity of up to 40% compared to
the viscosities of the controls. Commercial and purified CF alginate samples, both phage treated and un-
treated, were subjected to gel filtration chromatography by using Sephacryl High Resolution S-400 medium in
order to obtain evidence of degradation. The results demonstrated that alginate treated with phage had a lower
molecular weight than untreated alginate. The data suggest that bacteriophage migration through P. aerugi-
nosa biofilms may be facilitated by a reduction in alginate viscosity brought about by enzymic degradation and
that the source of the enzyme may be the bacterial host itself.
Pseudomonas aeruginosa is an opportunistic human patho-
gen that causes major problems in a number of clinical settings,
particularly in patients with burns or other wounds, patients
who have indwelling medical devices, and cystic fibrosis (CF)
sufferers. Patients with CF are prone to respiratory infections
caused by mucoid strains of P. aeruginosa, and these strains are
recalcitrant to treatment with antibiotics. This bacterium can
grow as a biofilm of considerable thickness (.200 mm) and can
secrete large quantities of alginate exopolysaccharide (14). The
exopolysaccharide surrounds the cells, forming a glycocalyx
that can act as a significant barrier to the penetration of anti-
biotics (2, 24). When grown in the biofilm mode, P. aeruginosa
may exhibit up to 100 times greater resistance to biocides than
the corresponding planktonic cells (3, 4, 27, 37).
In addition, the resistance of biofilm cells to b-lactams, to-
bramycin, quaternary ammonium compounds, and the quino-
lones has been attributed to a slow growth rate (10, 20, 23), a
condition common in biofilms (15, 25). Changes in growth rate
and nutrient limitation can also give rise to altered cell wall and
membrane structure (3, 14, 19).
As an alternative to the use of antibiotics, some workers
have attempted to use bacteriophages as a means of combating
bacterial infections, and this strategy has had some success (1, 6).
The concept of using phages as antimicrobial agents to treat
infections was initiated in 1915 when Twort and d’Herelle
independently observed the phenomenon of transmissible lysis
of bacteria. Bacteriophages were administered to cholera pa-
tients in an attempt to cure the disease, and the initial results
were encouraging. Bruynoghe and Maisin (11) later had some
success in treating staphylococcal skin infections with phage.
However, apart from a few isolated successes, the use of bac-
teriophages as treatment for bacterial infections did not
progress due in part to exaggerated claims based on a lack of
understanding but due principally to the advent of antibiotics
in the 1940s.
More recently, there has been renewed interest in the use of
bacteriophages as antimicrobial agents now that the spectre of
antibiotic resistance has become a reality. Smith and Huggins
(32) compared the efficacy of phage therapy with that of con-
ventional antibiotics by using Escherichia coli O18:K1 as a
model pathogen for mice. A single intramuscular dose of an-
ti-K1 phage was found to be more effective than multiple
intramuscular doses of antibiotics, and the bacteria did not
proliferate in the brains of the mice that had been inoculated
with phage. Smith and Huggins (33) also attempted to treat
diarrhea caused by enteropathogenic E. coli in calves, piglets,
and lambs. They found that the E. coli cells isolated after
treatment with phage were much less virulent than the parent
bacteria. Later, Smith et al. (31, 34) performed additional
studies on the control of diarrhea in calves with bacteriophage
and found that severe enteropathogenic E. coli diarrhea could
be cured with a single oral dose of 10,000 phage particles or by
feeding on litter sprayed with phage.
Cislo et al. (12) used phage successfully to treat patients with
postoperative skin infections caused by a variety of pathogens,
including P. aeruginosa, staphylococci, and Klebsiella sp.
Soothill (35) tested the efficacy of bacteriophage for treating
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experimental infections caused by Acinetobacter, Pseudomonas,
and Staphylococcus species. While the results of Soothill ex-
posed some of the limitations of phage therapy, they did dem-
onstrate that phage can be used to control bacterial infections
in a clinical setting. In a later study, Soothill (36) examined skin
grafts in guinea pigs artificially infected with P. aeruginosa with
and without bacteriophage treatment. After 5 days the grafts
took in six of seven guinea pigs treated with phage and failed
in all untreated animals.
There are a number of potential advantages of using bacte-
riophages to control infections; in particular, phages which are
highly specific for the infecting bacterium and thus are harm-
less to the host can be chosen. The initial dose of the phage can
be low since the virus multiplies in the bacterial cells, releasing
new phage particles on lysis. This process of enhancement of
the number of phage should continue until all the bacteria
have been destroyed. The problem of development of resis-
tance can be reduced by concurrent administration of a num-
ber of different phages, each of which acts on the same type of
cells. The phages are likely to be effective even against the
bacteria that are multiply resistant to antibiotics. Using bacte-
riophages to treat biofilm-associated infections, however, is
likely to be more problematic due to the presence of a glyco-
calyx that acts as a diffusional barrier to the virus (16, 17).
In this paper we describe an investigation into the ability of
bacteriophage to diffuse through the alginate matrix secreted
by P. aeruginosa in order to lyse the bacteria in a biofilm.
MATERIALS AND METHODS
Microorganisms, media, and maintenance of cultures. Bacteriophage F116,
together with its host, P. aeruginosa NCIMB 10548, was obtained from the Welsh
School of Pharmacy, University of Wales, Cardiff, United Kingdom. A second P.
aeruginosa bacteriophage, designated GL1, together with its host bacterial strain,
was obtained from the School of Pharmaceutical Sciences, University of Not-
tingham, Nottingham, United Kingdom. A mucoid strain of P. aeruginosa was a
respiratory clinical isolate obtained from a patient at Brighton General Hospital
(Brighton, United Kingdom) suffering from CF. The other bacteriophage sus-
pensions used were suspensions of E. coli lambda phage and a Staphylococcus
aureus bacteriophage, which was originally obtained as an environmental isolate.
Both of the latter bacteriophages were obtained from the culture collection at
the University of Brighton, Brighton, United Kingdom. All bacterial cultures
were stored frozen at 275°C in 10% glycerol. Every 2 to 3 weeks a vial of frozen
culture was thawed and propagated overnight in tryptone soya broth (TSB)
(Oxoid, Basingstoke, United Kingdom) at 37°C. The liquid cultures were used to
inoculate tryptone soya agar (TSA) (Oxoid), which was incubated at 37°C for 18
to 24 h. The plates were checked for purity, and individual colonies were iden-
tified by using the API 20E method.
Propagation and purification of bacteriophage. One milliliter of an overnight
culture of host bacteria was added to 100 ml of TSB and incubated in a shaking
incubator at 37°C. The optical density of the culture was monitored at 600 nm.
When the culture reached an optical density of 0.5, we added 1 ml of bacterio-
phage stock diluted in lambda buffer (containing [per liter of water] 0.73 g of
Trizma base, 0.5 g of gelatin, and 2.5 g of MgSO4 z 7H2O) to a concentration of
1 3 1010 PFU/ml. After mixing, the flask was kept stationary for 15 min, and then
shaking was resumed. Incubation was continued until bacterial lysis was evident
by visual inspection. When lysis had occurred, 10 ml of chloroform was added to
the flask, which was then shaken for a further 10 min at 37°C. The lysed culture
was cooled to room temperature, and sodium chloride was added to a final
concentration of 1 M. The NaCl was dissolved by swirling, and the preparation
was stored on ice for 1 h. Bacterial debris was removed by centrifugation at
11,000 3 g for 10 min at 4°C. Polyethylene glycol 10,000 was added to the
supernatant liquid to a final concentration of 10% (wt/vol) and was slowly
dissolved by stirring at room temperature. The mixture was left overnight at 4°C
to allow the bacteriophage particles to form a precipitate, which was recovered
by centrifugation at 11,000 3 g for 10 min at 4°C. The pellet was resuspended in
2 ml of lambda buffer, and 1 ml of chloroform was added; this was followed by
vortexing for 30 s. The organic and aqueous phases were separated by centrifu-
gation at 3,000 3 g for 15 min at 4°C, and the aqueous phase containing purified
bacteriophage was stored at 4°C until it was required.
Bacteriophage plaque assay. Bacteriophage samples were serially diluted 10-
and 100-fold in lambda buffer, and 0.1-ml portions were added to 5 ml of molten
overlay agar at 50°C. An overnight culture (0.1 ml) of the host bacterium was
then added to each preparation, and the molten agar was gently mixed before it
was poured over the surface of a TSA plate. The agar was allowed to set, and the
plate was incubated at 37°C for 18 to 24 h. The number of plaques that arose was
then counted, and the concentration of phage particles was expressed as the
number of PFU per milliliter. The assay was sensitive down to a concentration of
100 PFU/ml.
Preparation of bacterial biofilms. P. aeruginosa NCIMB 10548 biofilms were
grown on 12-mm-diameter discs of poly(methyl)methacrylate (PMMA). The
discs were prepared as follows. PMMA was dissolved in dichloromethane to a
final concentration of 10% (wt/vol). The solution was poured into a clean glass
tray and left under laminar airflow until the solvent evaporated. Discs were then
cut with a 12-mm-diameter circular cutter. The discs were placed individually in
the wells of a microtiter tray, an overnight culture of P. aeruginosa NCIMB 10548
was added, and the preparations were incubated for 2 h at 37°C. The discs were
then washed in three changes of sterile phosphate-buffered saline (PBS) to
remove nonadherent cells before being placed in fresh TSB. The discs were then
incubated at 37°C for up to 20 days with frequent changes of broth. Biofilms
grown under static conditions are exposed to increased environmental stress due
to stagnation and starvation compared to biofilms grown under flow conditions
(14). It has been suggested that this may lead to more confluent biofilms with
increased extracellular polysaccharide production and may also influence the
susceptibility of biofilms to biocides (8, 14). At intervals discs were removed,
washed twice in sterile PBS, and placed in 10 ml of sterile PBS. The biofilm cells
on each disc were removed by scraping with a sterile glass scraper, and the liquid
and disc were subjected to sonication for 4 min in a sonic bath. The resulting cell
suspension was serially diluted and plated onto replicate TSA plates for enu-
meration of viable cells.
Exposure of biofilms to bacteriophage. Discs containing 5-, 10-, 15-, and
20-day-old biofilms were washed twice in sterile PBS to remove nonadherent
cells and placed in individual wells of a microtiter tray. Control experiments were
carried out in which the adherent cells were removed and quantified to obtain
estimates of viable counts in the biofilms at different times. Based on these
estimates, a bacteriophage suspension was added to give final phage/cell ratios of
100:1 and 1,000:1, and the mixtures were incubated at 37°C for 24 h. At the end
of the exposure period the viable bacteria remaining in the biofilms were quan-
tified as described above. The experiment was repeated with cells removed from
biofilms of similar ages, and the planktonic cells were exposed at the same
phage/cell ratios in PBS.
Preparation and purification of P. aeruginosa extracellular polysaccharide.
Isolated colonies of a mucoid clinical isolate of P. aeruginosa from a CF patient
were suspended in 10 ml of sterile water. The resulting suspension was poured
over the surface of overdried TSA in an assay plate (12 by 12 in.). The plate was
sealed and incubated at 37°C for 3 days. After incubation the surface growth was
removed from the plate and transferred into sterile distilled water by using a
sterile glass spreader. The suspension was vortex mixed and centrifuged at
13,000 3 g for 1 h at 4°C. The supernatant liquid containing extracellular
polysaccharide was removed, and the pellet was discarded. Three volumes of
absolute alcohol was added to the supernatant liquid to precipitate the exo-
polysaccharide. The precipitate was finally redissolved in sterile distilled water to
produce a viscous solution, which was stored at 220°C prior to use.
Diffusion of bacteriophage through alginate gels. We used a glass, two-cham-
ber diffusion cell to investigate the ability of bacteriophage to penetrate alginate
gels containing different concentrations of alginate. The diffusion cell was pre-
pared by using 0.45-mm-pore-size membrane filters to enclose either pH 2 buffer,
solutions of sodium alginate (BDH Laboratory Supplies, Dorset, United King-
dom) at concentrations of 4, 6, 8, and 12% (wt/vol), or purified P. aeruginosa
extracellular polysaccharide. The donor chamber contained bacteriophage sus-
pended at a concentration of 1010 PFU/ml, while the receptor chamber contained
buffer alone. The entire unit was placed in a water bath at 37°C. Samples were
removed from the receptor chamber at intervals and assayed to determine the
phage concentration by the overlay plaque assay, using P. aeruginosa NCIMB
10548 as the indicator organism. Plaque counts of zero were recorded as 100
PFU/ml as this concentration was the limit of sensitivity of the assay.
Rheological analysis of alginate gels. Different concentrations of commercial
alginate (4, 6, 8, and 12% [wt/vol]) were prepared in sterile water. Five-milliliter
samples of each preparation were incubated with 0.1 ml of bacteriophage at a
concentration of 1010 PFU/ml. Controls were also prepared with 0.1 ml of
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lambda buffer in place of the bacteriophage and 0.1-ml samples of an autoclaved
bacteriophage suspension. All tubes were incubated at 37°C for 24 h. After
incubation 1-ml samples were subjected to a rheological analysis at 10 points by
using a Carrimed controlled stress rheometer operating at 25°C and frequencies
ranging from 1 to 10 Hz. The instrument was used in the oscillatory mode with
cone and plate geometry. Purified bacterial exopolysaccharide was inoculated
with bacteriophage as described above, and samples were removed for rheologi-
cal analysis at intervals over a 4-h period and after overnight incubation. The
experiment was repeated by using an 8% commercial alginate gel incubated with
bacteriophage at concentrations of 1010 and 1012 PFU/ml, and the rheological
characteristics were determined over a 4-h period. Bacteriophage were mixed
with 8% commercial alginate at a concentration of 1010 PFU/ml, and the mix-
tures were incubated at 4 instead of 37°C. An uninfected culture of P. aeruginosa
NCTC 10548 was grown in TSB at 37°C, and the whole culture was subjected to
the procedure used for bacteriophage purification. The purified bacterial extract,
devoid of bacteriophage, was added to 8% commercial alginate, and the mixture
was incubated at 37°C for 4 h. Samples were removed at intervals to assess the
reduction in viscosity. A variety of other bacteriophages were used in place of
F116 (P. aeruginosa phage GL1, E. coli lambda phage, and a staphylococcal
bacteriophage). These phages were incubated with 8% commercial alginate at
37°C, and samples were removed for analysis over a 4-h period.
Gel filtration chromatography of alginate samples. Commercial alginate and
purified P. aeruginosa exopolysaccharide, both freshly prepared and bacterio-
phage treated, were subjected to gel filtration chromatography to look for evi-
dence of polymer degradation. Sephacryl High Resolution S-400 medium was
used in a column (2.5 by 19 cm). The column was equilibrated with 200 ml of
lambda buffer (pH 7.2); the flow rate was 0.9 ml/min initially and was reduced to
0.65 ml/min when 2-ml samples were added to the reservoir. The outlet passed
through a flowthrough cuvette, and two detection wavelengths were used: 260 nm
for the commercial alginate samples and 249 nm for the bacterial exopolysac-
charide. These wavelengths were chosen on the basis of preliminary UV scans
conducted with each of the alginate gels.
RESULTS
Treatment of biofilms with bacteriophage. Biofilms of P.
aeruginosa NCIMB 10548 were prepared on sheets of PMMA
as preliminary experiments had shown that this was a substrate
to which the bacteria readily adhered and on which they grew
to higher densities than they grew on silicone rubber, glass, or
polystyrene. Anwar et al. (4) showed that a P. aeruginosa bio-
film grown for 7 days exhibited significantly greater resistance
to tobramycin than a biofilm grown for 2 days exhibited and
that the resistance of both of biofilms was much greater than
that of planktonic cells. Therefore, in this study biofilm growth
was allowed to proceed for up to 20 days. Exposure of biofilm
cells to bacteriophage for 24 h showed that there was a reduc-
tion in viable counts that was dependent on the initial ratio of
phage to cells and on whether the cells were attached to the
substrate (Fig. 1). A phage/cell ratio of 100:1 resulted in a 1-log
reduction in the viable cell number in an intact biofilm, while
the number of detached cells resuspended before bacterio-
phage exposure declined by just over 2 logs. When the ratio
was increased to 1,000:1, the log reduction factor for an intact
biofilm increased to 2, whereas the log reduction factor for
FIG. 1. Effect of bacteriophage on biofilms of P. aeruginosa. P. aeruginosa NCIMB 10548 biofilms were grown for 5, 10, 15, and 20 days. They
were treated with bacteriophage, and the numbers of surviving bacteria were determined. Bacteriophage/cell ratios of 100:1 and 1,000:1 were used
with both intact biofilms and resuspended biofilm cells. For all experiments n 5 6. The error bars indicate standard deviations.
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resuspended cells was 3. Younger biofilms did not seem to be
any more sensitive to bacteriophage than 20-day-old biofilms;
biofilms of all ages resulted in the same log reduction factors
for all treatments. For comparison, cells grown planktonically
in liquid cultures exhibited log reduction factors greater than
of 5 (data not shown), suggesting that the resuspended biofilm-
derived cells still had increased resistance to treatment.
Diffusion of bacteriophage through alginate gels and exo-
polysaccharide. The composition of bacterial exopolysacchar-
ides is complex and incompletely understood. Many bacteria
are known to produce extracellular polysaccharides during
planktonic growth, and it is not known whether the molecules
produced in the biofilm mode of growth are chemically differ-
ent polymers or whether they have different physical proper-
ties. It is generally agreed, however, that the exopolysaccharide
produced by P. aeruginosa is a polyanionic alginate that is a
block copolymer of mannuronic and guluronic acids. In order
to investigate the diffusion of bacteriophage through this exo-
polysaccharide system and to analyze the effects of different vis-
cosities, commercial alginate gels were prepared and com-
pared to exopolysaccharide purified from a mucoid strain of P.
aeruginosa. The rate of diffusion of bacteriophage through the
intermediate concentrations of commercial alginate (4, 6, and
8% [wt/vol]) was only slightly retarded compared to the rate of
diffusion through buffer, while diffusion through exopolysac-
charide was similar to diffusion through 4% alginate (Fig. 2). In
each case, however, the number of bacteriophage found in the
receptor compartment decreased as the viscosity of the gels
increased. Increasing the alginate concentration to 12% (wt/
vol) greatly inhibited bacteriophage diffusion over the 5-h ex-
periment. When incubated overnight, however, the bacterio-
phage was found to have penetrated into the receptor
compartment, albeit at a concentration 5 logs less than the
concentration in the buffer control.
Rheological analysis of alginate gels. The viscosities of com-
mercial alginate treated with bacteriophage were up to 40%
less than the viscosities of controls incubated for the same time
in the absence of phage (Table 1). The viscosities in the control
tubes, including those containing heat-killed bacteriophage,
were unchanged after overnight incubation. The experiment
was repeated with bacteriophage concentrations of 1010 and
1012 PFU/ml, and samples were taken for rheological analysis
at intervals for up to 4 h. The results indicate that there were
time- and concentration-dependent reductions in viscosity of
up to 40% compared to the viscosities of the controls (Fig. 3).
Phage-alginate mixtures incubated at 4°C did not exhibit any
reduction in viscosity over the same time periods (data not
shown). Purified exopolysaccharide from P. aeruginosa showed
a similar reduction in viscosity with time when it was treated
with bacteriophage (Table 2). In order to ensure that the
reductions in viscosity observed were not due to bacterial en-
zymes carried over in the purified bacteriophage suspensions,
a culture of uninfected P. aeruginosa was subjected to the
FIG. 2. Diffusion of bacteriophage through alginate gels. The rate of diffusion of bacteriophage was determined with commercial alginate gels
containing 4% (n ), 6% (), 8% (3), and 12% (p) alginate. The data were compared to the data for diffusion through a buffer control (}).
Bacteriophages were also assessed to determine their rate of diffusion through purified P. aeruginosa exopolysaccharide (F). For all experiments
n 5 6. The error bars indicate standard deviations. Phage counts of zero were recorded as 100 PFU/ml, which was the limit of detection of the
assay.
TABLE 1. Effect of bacteriophage addition on the viscosities of
different concentrations of commercial alginate
Alginate concn
(%, wt/vol)
Viscosity of untreated control
(mPa)
Viscosity after phage addition
(mPa)
4 2.76 6 0.0621a 2.077 6 0.03
6 17.95 6 0.011 12.95 6 0.09
8 25.39 6 0.339 15.21 6 0.043
12 112.78 6 2.752 88.85 6 0.183
a Mean 6 standard deviation (n 5 5).
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procedure used for bacteriophage purification. When samples
of the purified extract (diluted appropriately to reflect the
extent to which the phage stock was diluted) were added to
alginate solutions, the reduction in viscosity observed was sig-
nificantly less than that seen in the presence of bacteriophage
(P 5 0.022). A second suspension of purified P. aeruginosa
bacteriophage was tested in order to determine the specificity
of the interaction. The host bacterium of GL1 was a different
strain of P. aeruginosa, and GL1 was propagated from this
strain, although it was also lytic for NCIMB 10548. Figure 4
shows that GL1 was able to reduce the viscosities of the algi-
nate samples to the same extent as F116. The ability to reduce
the viscosity of alginate was restricted to Pseudomonas bacte-
riophages, however, since E. coli lambda phage and staphylo-
coccal phage did not reduce the viscosity compared to the
viscosity of the controls (Fig. 4).
Gel filtration chromatography of alginate samples. Com-
mercial alginate samples and purified exopolysaccharide be-
fore and after treatment with bacteriophage were analyzed by
gel filtration chromatography to assess the chain length profiles
of the gel systems. The absorbance readings for the commer-
cial alginate are shown in Fig 5, and the peak area of the
control sample represented 48.8% of the total area under the
curve. When a preparation was treated with bacteriophage, the
peak height for the major component was reduced by approx-
imately 60% and the peak area decreased to 25.6% of the total
area under the curve. Similar results were obtained with the
purified exopolysaccharide (Fig. 6); the peak height for the
major component of similar molecular weight was reduced by
approximately 75%, and the peak area expressed as a percent-
age of the total area decreased from 48 to 21% following phage
treatment. In both cases an obvious shift from larger molecules
to smaller molecules after bacteriophage treatment was evi-
dent, indicating that degradation of the polymer to shorter-
chain-length units occurred. The apparently reduced void vol-
umes observed for the phage-treated samples were attributed
FIG. 3. Effect of bacteriophage concentration on the viscosities of
commercial alginate gels. Gels containing 8% alginate were treated
with bacteriophage at concentrations of 1010 PFU/ml (}) and 1012
PFU/ml (n ), and the viscosities were measured with a Carrimed con-
trolled stress rheometer at different times. Controls consisted of gels
which were not treated with bacteriophage ().
FIG. 4. Effect of bacteriophage type on viscosities of commercial
alginate gels. Gels containing 8% alginate were treated with GL1 (}),
E. coli lambda phage (), and a staphylococcal bacteriophage (F).
Viscosities were measured with a Carrimed controlled stress rheome-
ter at different times.
TABLE 2. Effect of addition of bacteriophage on the viscosity of
purified P. aeruginosa exopolysaccharide
Time (h) Viscosity of untreatedcontrol (mPa)
Viscosity after phage addition
(mPa)
0.5 2.33 2.33 6 0.031a
1 2.35 2.22 6 0.019
2 2.32 2.18 6 0.023
3 2.35 2.11 6 0.011
4 2.34 2.06 6 0.015
18 2.33 1.76 6 0.037
a Mean 6 standard deviation (n 5 5).
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to the emergence of phage particles from the column prior to
the alginate peaks.
DISCUSSION
Growth of bacteria in planktonic form is relatively rare in
nature and tends, therefore, to be confined to unrepresentative
laboratory cultures. The more common mode of growth in
natural environments involves adhesion to a substrate in the
form of a biofilm, usually in a mixed consortium of cell types
(9, 14, 29, 39, 40). Under these conditions the bacteria fre-
quently express phenotypic characteristics different from those
seen in planktonic cultures, and the rate of growth can be very
low (3, 14, 19). Biofilm growth has several advantages for
adherent cells, including better access to nutrients, possibilities
for genetic exchange, and protection against desiccation and
predation (22). Secretion of exopolysaccharide, which not only
impedes phagocytic cells but also imposes diffusional con-
straints on materials entering and leaving the system (13),
enhances the protective function of the biofilm. Furthermore,
the cells embedded in a biofilm are protected by the architec-
ture of the biofilm itself. In a clinical setting the presence of
exopolysaccharide has been shown to have a dramatic effect on
the ability of antibiotics to control biofilm-associated infec-
tions. Patients with CF who acquire mucoid P. aeruginosa in
their lungs very rarely eradicate it, while some infected medical
implants can be treated successfully only if the device is re-
moved from the body.
In this study P. aeruginosa was chosen not only because it is
of clinical significance when it is growing as a biofilm but also
because the nature of the exopolysaccharide is well under-
stood. It should be noted, however, that the highly charged,
polyanionic character of the alginate exopolymer is not typical
of most bacterial exopolysaccharides. There is much diversity
in the exopolysaccharides secreted by different bacterial spe-
cies, and for this reason care should be taken when attempts to
extrapolate results from one system to another are made. In-
deed, secretion of alginate by different strains of P. aeruginosa
is highly variable; the CF clinical isolate used in this study
produces copious quantities, while NCIMB 10548 secretes
much less.
Bacteriophages occur in large numbers in natural ecosys-
tems and undoubtedly have a significant influence on the bac-
terial populations present (28, 30). However, very little work
has been done on the effects of bacteriophages on bacterial
cells embedded in biofilms (5, 16, 17). Recently Hughes et al.
(26) examined a lytic bacteriophage active against biofilms of
Enterobacter agglomerans and found that the bacteriophage
stimulated production of polysaccharide depolymerases by the
bacteria. These enzymes were capable of degrading the exo-
polysaccharide produced by E. agglomerans biofilms, which
clearly assisted bacteriophage dispersal.
If bacteriophages are to exert control over biofilm bacteria,
they must first be able to reach the embedded cells by migrat-
ing through the exopolysaccharide. Then they must locate the
specific adhesion sites on the cell wall before entering a cell by
utilizing its own metabolism to propagate new viruses. Each of
these stages places considerable burdens on a bacteriophage,
not least because phages are not intrinsically motile. However,
Drury et al. (18) have shown that 1-mm-diameter latex particles
are capable of diffusion through P. aeruginosa biofilms that are
approximately 34 mm thick within 24 h. A similar problem
confronts mammalian viruses that must penetrate a viscous
covering of mucus in order to attack underlying epithelial cells.
Very little information has been published in this area, but
Bisaillon et al. (7) have shown that reovirus s1 protein pos-
FIG. 5. Gel chromatography of commercial alginate gels before
treatment (a) and after treatment (b) with P. aeruginosa bacteriophage.
FIG. 6. Gel chromatography of purified P. aeruginosa exopolysac-
charide before treatment (a) and after treatment (b) with P. aeruginosa
bacteriophage.
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sesses glycosyl hydrolase activity which degrades mucus to aid
diffusion. In addition, insect baculovirus possesses an enhancin
in its outer coat which is a metalloprotease enzyme capable of
degrading insect intestinal mucins. The insect intestinal mucins
are composed of glycoproteins and have structural similarities
to mammalian mucins. Degradation of the insect intestinal
mucins by the enhancin leads to higher viral infection rates
(38).
The results reported here clearly demonstrate that bacterio-
phage can reduce the number of viable bacteria in a biofilm by
up to 99% despite the presence of exopolysaccharide. Biofilm
cells that were detached from the substrate surface and resus-
pended before exposure, however, had increased susceptibility,
showing that biofilm architecture does play an important role
in limiting access to bacteriophage. A similar picture has been
reported for biocide treatment of biofilms. Surface-adhered
Listeria monocytogenes cells were shown to exhibit much
greater resistance to benzalkonium chloride. Removal of the
adherent cells from the surface increased their biocide sensi-
tivity, but they were still not as sensitive as planktonically
grown cells (21). The data suggest, therefore, that bacterio-
phages are capable of penetration through a gel network by
diffusion. The failure to obtain levels of killing comparable to
those seen with planktonic cells may be a reflection of other
differences, such as the cellular metabolic rate.
Experiments were performed with purified bacteriophage
suspensions in the absence of host bacteria in order to test the
ability of the phage to diffuse through gel systems having dif-
fering viscosities. The results showed that even at the highest
concentration of alginate used (12%, wt/vol), bacteriophage
could penetrate during prolonged incubation. At the lower
concentrations of commercial alginate and in the presence of
purified P. aeruginosa exopolysaccharide, phage diffusion was
rapid. The viscosity of alginate gels is affected significantly by
the cation concentration, and high concentrations of Ca21, for
example, result in significant cross-linking. However, in natural
environments the amount of calcium is expected to be low; for
example, the concentration of calcium found in lung secretions
is approximately 6 mM, which would not cause significant
cross-linking. The purpose of these experiments was to deter-
mine whether the bacteriophage was able to influence polymer
chain length rather than the degree of cross-linking, and so no
additional calcium was included in the buffer solutions.
The flow characteristics of polymeric gel systems are com-
plex and can be described in terms of viscoelastic behavior.
The Carrimed controlled stress rheometer enables accurate,
nondestructive analysis of rheological characteristics over a
wide range of sheer stresses. The results presented here show
that addition of bacteriophage to solutions of alginate reduced
the viscosities of the gel systems in a manner that was concen-
tration and time dependent. The viscosities of alginate solu-
tions may be altered by changing the degree of cross-linking or
decreasing the polymer chain length. The polyanionic nature
of alginate gels means that the cation cross-linking can be
easily reversed. It is possible, therefore, that the reduction in
viscosity was merely due to the phage particles neutralizing the
Ca21 ions which were cross-linking the polymers. The data
presented above for heat-treated bacteriophage suspensions
suggest that this was not the case and are reinforced by the
observation that the kinetics of viscosity reduction, particularly
the temperature dependence, resembled an enzymatic process
that resulted in polymer degradation. The reduction in viscos-
ity also appeared to be highly specific, as other bacteriophages
(E. coli lambda phage and staphylococcal phage) did not have
any effect compared to controls.
Enzymatic degradation of the alginate polymer was con-
firmed by analyzing the gels by column chromatography. Sam-
ples that had been exposed to bacteriophage clearly showed
that there was a reduction in polymer size compared to the size
in the controls.
The bacteriophage suspensions used in this study were
highly purified from the original culture lysate, but it is possible
that the depolymerase enzyme responsible for alginate degra-
dation may have been present as a contaminant. When the
extract from a whole-cell culture of P. aeruginosa was subjected
to the procedure used in the phage purification process, the
resulting solution did possess some depolymerase activity, but
it was significantly less than that shown by the bacteriophage
suspension (P 5 0.022). This suggests that low levels of algi-
nate-degrading enzyme are present in the host bacterium itself.
Bacteriophage may, therefore, upregulate production of the
alginate depolymerase enzyme by the bacterium during lysis
and may subsequently utilize this enzyme (possibly by adsorb-
ing it to its coat proteins) to assist penetration of biofilm
exopolysaccharide.
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